High-Risk HPV Detection in Paraffin-Embedded Tissue from Cervical Lesions

Author:

Almeida Micaela1234ORCID,Caeiro Vitor15ORCID,Costa Diana1,Silva Lara1,Sousa Cíntia1,Pestana Paula145,Campelos Sofia23ORCID,Vale João23ORCID,Ramalhinho Ana Cristina145ORCID,Fonseca-Moutinho José145,Breitenfeld Luiza14ORCID

Affiliation:

1. Health Sciences Research Centre (CICS), Faculty of Health Sciences, University of Beira Interior (UBI), Avenida Infante D. Henrique, 6200-506 Covilhã, Portugal

2. Department of Pathology, Ipatimup Diagnostics, Rua Júlio Amaral de Carvalho, 45, 4200-135 Porto, Portugal

3. I3S—Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal

4. Clinical Academic Centre of Beiras (CACB), Edifício UBImedical, Estrada Municipal 506, 6200-284 Covilhã, Portugal

5. Cova da Beira Local Health Unit, Alameda Pêro da Covilhã, 6200-251 Covilhã, Portugal

Abstract

Background: Human papillomavirus (HPV), a leading cause of cervical cancer, is present in most cases of the disease and ranks as the fourth most common cancer in women globally. Among the HPV types, fourteen (HPV 16/18/31/33/35/39/45/51/52/56/58/59/66/68) are recognized as high-risk (hrHPV), each with varying levels of oncogenic potential. Detecting and genotyping these hrHPV types in cervical lesions is crucial, requiring the development of new diagnostic methods. Methods: This study focuses on a retrospective analysis conducted on 44 women from the Cova da Beira Local Health Unit. We used the Anyplex™ II hrHPV Detection kit for hrHPV genotyping from paraffin-embedded cervical tissue samples. Results: hrHPV types were identified in 38 out of the 44 women. Genotyping revealed HPV-16 (55.3%), HPV-18/39/56/58/59 (5.3%), HPV-31 (21.1%), HPV-35 (7.9%), HPV-51/66 (2.6%), and HPV-52 (10.5%). Conclusions: This study demonstrates that the Anyplex™ II hrHPV Detection kit, originally designed for cervical cancer screening, is also effective for hrHPV genotyping in histological analyses. This methodology offers a simpler and more cost-effective approach for cervical cancer risk stratification. Its implementation in clinical practice could enhance the detection of hrHPV in cervical lesions, thereby contributing to more precise diagnoses and potentially more informed treatment strategies.

Funder

scope of the CICS-UBI

Portuguese Foundation for Science and Technology/MCTES

FCT fellowship

Publisher

MDPI AG

Reference17 articles.

1. Warts and all: Fingolimod and unusual HPV-associated lesions;Triplett;Mult. Scler.,2019

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

3. A review of human carcinogens—Part B: Biological agents;Bouvard;Lancet Oncol.,2009

4. Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis;Arbyn;Lancet Glob. Health,2020

5. World Health Organization (2021). WHO Guideline for Screening and Treatment of Cervical Pre-Cancer Lesions for Cervical Cancer Prevention, World Health Organization. [2nd ed.]. Licence: CC BY-NC-SA 3.0 IGO.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3